Is it possible to successfully purchase Opicapone in the country?

Opicapone is a new oral drug mainly used to treat patients with Parkinson's disease, especially those who have failed to respond to levodopa. As a selective COMT inhibitor, opicapone can prolong the action time of levodopa, thereby improving the motor symptoms of patients with Parkinson's disease, reducing the occurrence of "switching phenomenon" and improving the quality of life.

At present, Opicapone is not yet on the market in China, so patients cannot purchase the drug through formal channels. This situation means that patients who need the drug must rely on overseas channels to purchase it. Although Opicapone has been approved and launched on the drug market in some countries and regions. For example, the original version of the drug can be found in the European market, and its price is approximately more than 2,000 yuan. However, due to the lack of generic drugs, the financial burden on patients may increase. In addition, since purchasing drugs across borders involves legal and logistical issues, patients need to be extra cautious when choosing a purchase method to ensure the legality and safety of the drugs.

Although the clinical trial results of Opicapone show that it has significant advantages in improving the therapeutic effect of Parkinson's disease patients, because there are currently no sales channels in China, patients still need to rely on other existing therapies during the treatment process, such as the combined use of levodopa and other auxiliary drugs. For those who wish to try opicapone, they should first discuss treatment options with their primary care physician to assess whether the drug is suitable for use and to understand the potential risks and benefits.

If patients really want to try overseas Opicapone, they need to fully understand the relevant import regulations and choose corresponding overseas drug purchase channels to avoid health risks caused by non-standard drugs. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.

Reference materials:https://www.ongentys.com/